4Tan M.Graniseron:new insights into its use for the treatment of chemotherapy induced nausea and womiting[J].Expert opin pharmacother,2003,4(9):1563.
5Stoltz R,Parisi S,Shah A,et al.Pharmacokinetics,metabolism and excretion of intravenous -palonooetron in healthy human volunteers[J].Biopharm Drug Dispos,2004,25(8):329.
6Aapro E,Selak M,Lichinitser D,et al.Palonosetron (PALO)is more effective than ondansetron (OND) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients recerving moderately emetogenic chemotherapy (MEX):Results of a phase III trial[J].Proc Am Soc Clin Oncol,2003,22:726.
2GRALLR R,LICHINISTER M,VAN DER VEGT S,et al. Palonosetron improves prevention of chemotherapy induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase Ⅲ trial comparing single doses of palonosetron with ondansetron [ J ]. Ann Oncol, 2003,14 ( 10 ) : 1570 - 1577.
3EISENBERG P, FIGUEROA-VADILLO J, ZAMORAL R, et al. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiling with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist : results of a phase Ⅲ, single-dose trial vs dolasetron[ J ]. Cancer, 2003,98 ( 11 ) :2473 - 2482.
4RUBENSTEIN EB. Palonosetron :a unique 5-HT3 receptor antagonist indicated for the preventing of acute and delayed chemotherapy-induced nausea and vomiting [ J ]. Clin Adv Hematal Oncnl, 2004,2(5) :284 -288.
5STOLTZ R, CYONG JC, SHAH A, et al. Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor anlagonist,in US and Japanese healthy subjects [ J ]. J Clin Pharmacol,2004,44(5) :520 - 531.
6Endo T, Minami M, Kitamura N, et al, Effects of Various 5 - HT3 receptor antagonists, granisetron, ondansetron, Ramosetron and azasetron on serotonin(5 -HT) release from the ferret isolated ileum [J]. Res Comnun Mol Pathol Pharmacol, 1999,104 (2) : 145 - 155.
9Schwartzberg LS.Chemotherapy-induced nausea and vom- iting:clinician and patient perspectives[].J Support Oncol.2007
10Kris MG,Hesketh P J,Somerfield MR,et al.American Socie- ty of Clinical Oncology guideline for antiemetics in oncology: update 2006[].Journal of Clinical Oncology.2006
8Roila F, Hesketh P J, Herrstedt J, et al. Prevention of chemotherapy and radio therapy induced emesis: resultsof the 2004 Perugia International Antiemetic Consensus Con- ference[J]. Ann Oneol, 2006, 17(1): 20.
9Thongprasert S. Efficacy and tolerability Of tropisetron in the prevention of cisplatin - induced nausea and vomiting in ad- vanced non-small cell lung caneer[J]. Acta 0ncol, 2000, 39(2): 221.
10Gralla R, Lichinitser M, van Der vegt S, et al. Palonosetron improves prevention of chemotherapy- induced nausea and vomiting following moderately emetogenic chemotherapy: re- sults of a double - blind randomized phase 111 trial comparing single doses of palonosetmn with ondansetron[J ]. Ann On- col, 2003, 14(10): 1570.
